Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The only change is a revision update from v3.3.1 to v3.3.2 with no changes to study content visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.3.1 added; v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:48:18.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Funding-status notice removed. The page content remains focused on the study details and locations.
    Difference
    0.4%
    Check dated 2025-11-17T06:30:13.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected in the page context; the study details for NCT03113487 remain intact as presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:11:27.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T09:50:11.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    - Version indicator updated from v3.0.2 to v3.1.0, signaling a new release.
    Difference
    0.1%
    Check dated 2025-09-28T03:11:10.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.